Skip to main content

Table 4 Sensitivity analysis testing the probability that screening participation or invitation-to-screening is cost-effective

From: Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy

 

INMB

Probability cost-effective

WTP (€ per QALY) 30,000

WTP (€ per QALY) 50,000

WTP (€ per QALY) 30,000

WTP (€ per QALY) 50,000

Screening participation (group P vs. group C)

 Base-case

368

959

0.79

0.89

 High prob of LC (p LC  = 6.79 %)

609

1376

0.86

0.92

 Low prob of LC (p LC  = 4.2 %)

160

600

0.67

0.84

 Alternative QoL

134

568

0.63

0.80

 Higher costs

265

856

0.72

0.87

Invitation-to-screening (group I vs. group C)

 Base-case

365

692

0.95

0.97

 High prob of LC (p LC  = 4.73 %)

438

816

0.96

0.97

 Low prob of LC (p LC  = 3.68 %)

311

601

0.94

0.97

 Alternative QoL

260

519

0.90

0.93

 Higher costs

339

667

0.94

0.96

  1. INMB incremental net monetary benefit, WTP willingness to pay, LC lung cancer